What is AIVF?
AIVF is a medical technology company dedicated to empowering fertility clinics with advanced intelligence. Its core offering is an AI software platform designed to streamline and standardize processes within IVF patient care, thereby accelerating data-driven decision-making. By partnering with leading global clinics, AIVF actively contributes to research and innovation in reproductive medicine. Founded in 2018 by reproductive medicine experts Daniella Gilboa and Prof. Daniel Seidman, the company is headquartered in Tel Aviv, Israel.
How much funding has AIVF raised?
AIVF has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2022): $25M with participation from Insight Partners and 166 2nd Financial Services
Key Investors in AIVF
Insight Partners
Insight Partners is a venture capital firm known for its focus on scaling software companies. Their involvement suggests a belief in AIVF's potential for rapid growth and market leadership in the fertility technology space.
166 2nd Financial Services
166 2nd Financial Services is an entity participating in the funding round, indicating financial backing for AIVF's strategic objectives.
What's next for AIVF?
The recent major strategic investment in AIVF signals a pivotal growth phase, likely aimed at scaling its AI-driven fertility intelligence platform. This Series A financing is expected to fuel further product development, market expansion, and the enhancement of its partnerships with reproductive medicine clinics worldwide. The company's focus on automating and standardizing IVF patient care positions it for significant impact in a rapidly evolving field.
See full AIVF company page
